{"name":"Third Arc Bio","slug":"third-arc-bio","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ARC101","genericName":"ARC101","slug":"arc101","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ARC101","genericName":"ARC101","slug":"arc101","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPcG9rd3R4WDNoMmRSQ0hGdjIzeDlocm5MeDU4NHlfRGI4eXVWa2xaRVQyRkJZT25VNGJaaEN1VzF0U2k0OE42bEhtYUJxczJVa29hUlZlWm9sLTlzcllJZzFVVXE1UTRHN2VONXVmc1daX01GZWhDMmJrQlkybVVRZmhhbTBwa2JDQ1ZVQ2QtUUZGWklhOHEySXczaFV3NGN1Zmg0MFQxU1RiVy1iWkE?oc=5","date":"2026-02-22","type":"pipeline","source":"MedCity News","summary":"Startup Korsana Bio Reveals $175M Raised for a Better Brain-Penetrating Alzheimer’s Drug - MedCity News","headline":"Startup Korsana Bio Reveals $175M Raised for a Better Brain-Penetrating Alzheimer’s Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQRHh5RnphUXNJMEJ2MEpfQ3BSV25JLVJVY3ZZU3loOXExUWRuSkhnd3p0Mkc4WXhuRFdkY1p0eDhzRW51eHpkaEdKQmswTjB0ZGNRRTlQX0lkZUJyUnAwQzVaYWZzVTMyMXVTVEFlSF9ONDRRZlZYb0pSbUhMRzZiS2RzQWxGelNRZTJtcTFVT3Uzd3psV1NQdGlDb0FkdHV6V2RCRG1CQ09FTGZKTHJaX0tn?oc=5","date":"2026-02-05","type":"pipeline","source":"BioCentury","summary":"Angitia’s latest megaround to fuel mid-stage milestones: Venture Report - BioCentury","headline":"Angitia’s latest megaround to fuel mid-stage milestones: Venture Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNeTM4SFlmM1dQdnBHcWF5U2R3bGM1MHhEajZ4S0pndWZ4SERoWTVrSDN1dlYwZmFQMFAwSkhzeG1FZnpCRThyU2dFMDRidVBsN1gtSlNlV012NE44bndfd0JNRDkzeDlWeTJXU1pXXzJ4ZW5haU1LUnpZYklPR3MtdGltT3A5aGVnVGg0Qkg0aUEtZ0puRmxwNkQtQQ?oc=5","date":"2026-02-04","type":"pipeline","source":"The Pharma Letter","summary":"Third Arc Bio closes $52 million Series A extension - The Pharma Letter","headline":"Third Arc Bio closes $52 million Series A extension","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxPU2s3VUNtcGEzdkJqR2tweDNjcmlwcXdRTEtyY1lOa1ZKbDNndmdfUl9RMTFTb21qOHc3eWxRd0xzNzcxalFMcUUtdGlzRUEyQldfVVhHLVVBNlRldm9rN0MycWJFZmtEU3RRVG00YTRZWF9nd0NreENYRzh3cmhNMllVU2RwdFllVHphUElHQ0RZRWpwN01PUDFzaFgyeEQwTElxNjE0YlZRV1ozRFRNUmtBSTN5Y0NfanBtdW5XUmZwY0JCdGJ2OHhxdVJFWlJqRGFaN3Y1X3hBXzI1OVNLbzE2ZndiVzA1cU13ZVZsWmZrdw?oc=5","date":"2026-02-04","type":"pipeline","source":"PR Newswire","summary":"Third Arc Bio Announces $52M Series A Extension to Expand Oncology and Immunology & Inflammation Portfolio - PR Newswire","headline":"Third Arc Bio Announces $52M Series A Extension to Expand Oncology and Immunology & Inflammation Portfolio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPNVdOOXdQd3BTVEVXUVVYR1Jueld2Z2tGdUpMS2NVUkNQQndPdVBmYzJRc054dDkzWjdqa05ROGI1cGpCcUdsckxQTFUxczY5NFhYd00takQ5YmhPdTdkaVBWNUs0Q05MM3p1WXE5UnVmWDVPdHVhSWZMMlA3czNuczhCU2RtY1dmSGo0M1N0U1ptODZPWEtha1R6dk9QaXBTWmtkbTh3?oc=5","date":"2026-02-04","type":"pipeline","source":"The Business Journals","summary":"Montgomery County's Third Arc Bio raises another $52M led by top Silicon Valley VC firm - The Business Journals","headline":"Montgomery County's Third Arc Bio raises another $52M led by top Silicon Valley VC firm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPbDRaQzVGVzA5V2FxbThkdFpZWFEtY0ExdW5MTkFCLVF0clhSVUpFWHFqdC0tVmo1R0ZmT21CSUphMW5nT3BkT3hLVnpXc3BNRFF0bjVBZWRiU2xjNXRJMDdVVGxrd1ZZVklfOWFkZ3VFYXRKWG42U09CUnEzVEFaamlfYzBmeW1IM2I1VE5n?oc=5","date":"2025-11-24","type":"pipeline","source":"BioXconomy","summary":"Eyes on Asia: Sanegene Bio, ABL Bio, Third Arc Bio - BioXconomy","headline":"Eyes on Asia: Sanegene Bio, ABL Bio, Third Arc Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNZWpQWUJoWUJIOWpwSUdCMVhmT1VTdkVpOXpVcjNmWTR3bWFSbUNKQVlYa1BwM2E2X1l4dl95Ujh3am5mei16RFdaQ2huLTU2R2cxcFd0U0kyN1hFWncyQlI3QXVXSDZyeHp1a19jdjFwcUJZZzR4M3NDbzJiZEpTa29YN0lPRWN0cDdpQmpzQmFmSTBBUVhJZHdNUlFUU2lweWVjMkFCMUQ?oc=5","date":"2025-11-14","type":"trial","source":"Fierce Pharma","summary":"Fierce Pharma Asia—Pfizer's PD-1xVEGF trials; ivonescimab's 1st survival win; Lilly's deal spree - Fierce Pharma","headline":"Fierce Pharma Asia—Pfizer's PD-1xVEGF trials; ivonescimab's 1st survival win; Lilly's deal spree","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOTVZ3d3BwRUxHZkJFYVNxdWZET0loWHpsek10Tk5KMTJYbWFNUGlCdDhSWVJ6V2M3RTFsR2lvT2tmcTA2TXZEYjE5WTBoRzdaTC1rMmpTQkpaZGVSMXZ6bUZTTXBPd3FMZTVCVGNoU2V6V2REc0ZnZW5tdFVPT1pBZl9YYmh4M29nS2VMTERDOHpIMnlZaW44VjctT0FqTkxCREFFalJadHdLTk9i?oc=5","date":"2025-11-13","type":"pipeline","source":"Fierce Biotech","summary":"Third Arc Bio pens back-loaded $840M pact for Adagene's masking T-cell engager tech - Fierce Biotech","headline":"Third Arc Bio pens back-loaded $840M pact for Adagene's masking T-cell engager tech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBQSDZyRVVLSkZydGI2MVdjZk1qUFYxQVF6SXNWUzUtM1ZDME1yd0psSjlvMTNqY1AxU29lUi1YcjV0eTgzSWVSYjNTUjZpbDJFUEhJ?oc=5","date":"2025-11-13","type":"pipeline","source":"FirstWord Pharma","summary":"Adagene inks milestone-heavy T-cell engager pact with Third Arc Bio - FirstWord Pharma","headline":"Adagene inks milestone-heavy T-cell engager pact with Third Arc Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNWEJmRldIb1ZvQXFSd3VzV200blpKSEdsSkFwZUROZV9wZ2RScnNLT2FJdUcxYkJzMUNjdW8yVG95QW9nWmRvN1Zmd0NERGJfSmJHSl9nazZIaHM2SmxadzZ6S0xoS0oxRElXZjVNTkZZQkhIdDNOcmdJeENucXZBSWhEOHJVUGhONmhSdzU4WV9lbDhxQjhvbjNrcmRhbkplbGRPVmpR?oc=5","date":"2025-11-13","type":"pipeline","source":"BioSpace","summary":"Recently Launched Third Arc Turns to China for Cancer T Cell Engagers - BioSpace","headline":"Recently Launched Third Arc Turns to China for Cancer T Cell Engagers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxOZl9jdkJUNm9VN1FIM3NURUNaMGZ2SzlUdXVUY1BCQ2NtOEZlNFptVmNULTJTU1pPMGRjSHFhRlM0NFBJbFl4TXFRb3RDUHpDYkludlpPNWtWWHhWM2U4UFNKUnAweDFDSVJPMEYxdzZxRnJaYkswZGx6Y3RUeTZ4ZXlBMzc5cUx1RElqT2xPaExuclN5X0dEUENaeWVORjFaUWkzNHFZT0d4ZzJ3UnNKVGQtUGZnR0pjTzJkNlVTQm00UUo0TVZYWTdZZXlaNmdFVzlmZndTRlhnY0Q4N29uYUs3VGM1VFkza19lMVQ4MEF6NVFrOTB0cTFiZjNDQzF5cV9kY1BXNFdoNEQ0RmlLQkpybEh0YUljME00d2ZwRlpoaEs4ZjlNV0dhbDJZc1dLWXc?oc=5","date":"2025-11-13","type":"pipeline","source":"GlobeNewswire","summary":"Adagene Announces Licensing Agreement with Third Arc Bio - GlobeNewswire","headline":"Adagene Announces Licensing Agreement with Third Arc Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxPY3hnT2JsLURKQTNlZ25TOUc3MDViSXpkRGZRcjBzdXZkd20zMVc3RkNwdTRLdzVJSjVYMGFOMXNwWUlfcHRCd0ZzNTF3TzZTTUVoSkJqSGt6cXY0OTlEdEo0OFQtQlJVSDZ2TW4zbWRibHBRc2hDYm9qdy1RLVNfZ2g2ZXY4MVNmT3NOQXUxN3pqMUdMcVVhaWNCZU9xSmtKWGo4WWFIcmV3TVBXMG50YkZsbFRGZ0pOaTZsUTFFd2lhOWRUTHBFWDZfOHI1ME1NUXdUeDdfTWRqSldZWUFlbUtURUE3M3B1MHhhX09lLW9KcFcwRFhDa2pzeXk5dEE4?oc=5","date":"2025-09-19","type":"trial","source":"Business Wire","summary":"Endpoints News Announces the 2025 Winners of the Endpoints 11 Awards, Highlighting Biotech’s Most Promising Startups - Business Wire","headline":"Endpoints News Announces the 2025 Winners of the Endpoints 11 Awards, Highlighting Biotech’s Most Promising Startups","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}